PHVS
Pharvaris BV
NASDAQ: PHVS · HEALTHCARE · BIOTECHNOLOGY
$30.09
+1.38% today
Updated 2026-05-08
Market cap
$1.97B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.48
Dividend yield
—
52W range
$15 – $31
Volume
0.3M
Pharvaris BV (PHVS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-65.20%
ROA
-35.80%
Debt/equity
0.00x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $0.00 | $-4.31M | — | — | — |
| 2019 | $0.00 | $-8.98M | — | — | — |
| 2020 | $0.00 | $-29.62M | — | — | — |
| 2021 | $0.00 | $-42.73M | — | — | — |
| 2022 | $0.00 | $-76.33M | — | — | — |
| 2023 | $0.00 | $-100.88M | — | — | — |
| 2024 | $0.00 | $-134.22M | — | — | — |
| 2025 | $0.00 | $-175.70M | — | — | — |